Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting safety and efficacy results for a treatment of Painful Diabetic Neuropathy, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Helixmith investigational product for Painful Diabetic Neuropathy

Snippet

Sponsor: Helixmith Co., Ltd. | Conditions: Painful Diabetic Neuropathies | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03